Abnormal expression of E-cadherin in tumor cells is associated with poor prognosis of gastric carcinoma.
about
Clinical significance of MET in gastric cancerMolecular classification of gastric cancer: Towards a pathway-driven targeted therapyPrognostic significance of MET amplification and expression in gastric cancer: a systematic review with meta-analysisThe clinical and functional significance of c-Met in breast cancer: a reviewExpression of MACC1 and c-Met in human gastric cancer and its clinical significance.PRL-3 and E-cadherin show mutual interactions and participate in lymph node metastasis formation in gastric cancerC-Met as a prognostic marker in gastric cancer: a systematic review and meta-analysis.Clinical significance of hepatocyte growth factor/c-Met expression in the assessment of gastric cancer progression.c-Met in esophageal squamous cell carcinoma: an independent prognostic factor and potential therapeutic targetPrognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma.The clinicopathologic association of c-MET overexpression in Iranian gastric carcinomas; an immunohistochemical study of tissue microarrays.MET in gastric cancer--discarding a 10% cutoff ruleClinicopathological Significance and Diagnostic Accuracy of c-MET Expression by Immunohistochemistry in Gastric Cancer: A Meta-Analysis.Knockdown of c-MET induced apoptosis in ABCB1-overexpressed multidrug-resistance cancer cell lines.Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients.C-Met in invasive breast cancer: is there a relationship with the basal-like subtype?Clinical and prognostic value of the C-Met/HGF signaling pathway in cervical cancer.Clinical value of CagA, c-Met, PI3K and Beclin-1 expressed in gastric cancer and their association with prognosis.Translating epithelial mesenchymal transition markers into the clinic: Novel insights from proteomics.12-Lipoxygenase promotes invasion and metastasis of human gastric cancer cells via epithelial-mesenchymal transition.
P2860
Q26776190-9499807C-5D04-4DA5-AB5A-8224834FBBC1Q26798420-A9009A7F-E678-493C-A9EE-43E388704A8DQ27027981-C7E4CCF7-E321-425F-B26A-E73FC09A2841Q28081415-5EB76B0F-E1AB-44CD-9091-D3620BAE5381Q33643400-03FBC98D-F5F5-4B9D-BDC6-9552FF4DEAF9Q33935399-B3F48C76-8D4D-427A-84C4-A9ADCC57D30BQ35041171-ADA1844A-0721-4739-AD70-5090257D9220Q35201636-407E2F7B-DFF3-49AF-9608-42246F77CA59Q35650167-50BA5E82-8407-4D7D-B346-81650B5A660DQ35854310-966AC597-C8E9-4178-88EE-C88A80CAB07DQ36127679-F343E9AE-00E2-4EAC-91B0-B572CD7D6789Q36554574-0994DBCA-B0B2-4B06-92D2-975AD9FA3327Q37342442-166A2F83-EEE9-45F8-A6DC-F3A4EB809E09Q38882892-7A5D2FAB-D4E1-4877-82A0-91D6EE34450DQ39038837-68B0B68E-688D-4E51-9755-86545B80E144Q39327784-5FDCDBF7-497A-4CA3-8CB4-C190B0A9D2F3Q47616848-EC3911CE-FE95-4646-9F0E-D6CF924E3DA3Q49217116-F065ECC5-C821-4EEB-8E08-EF87C4050947Q55217703-CC6B4765-A3C0-418F-9F12-6AF424D1BE27Q55619557-B8C47781-CBEA-4ADD-B8DE-AA07763C715A
P2860
Abnormal expression of E-cadherin in tumor cells is associated with poor prognosis of gastric carcinoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Abnormal expression of E-cadhe ...... rognosis of gastric carcinoma.
@en
Abnormal expression of E-cadhe ...... rognosis of gastric carcinoma.
@nl
type
label
Abnormal expression of E-cadhe ...... rognosis of gastric carcinoma.
@en
Abnormal expression of E-cadhe ...... rognosis of gastric carcinoma.
@nl
prefLabel
Abnormal expression of E-cadhe ...... rognosis of gastric carcinoma.
@en
Abnormal expression of E-cadhe ...... rognosis of gastric carcinoma.
@nl
P2093
P2860
P356
P1476
Abnormal expression of E-cadhe ...... rognosis of gastric carcinoma.
@en
P2093
Chuang-Qi Chen
Dong-Jie Yang
Jian-Bo Xu
Shi-Rong Cai
Wei-Ling He
Wen-Hua Zan
Yu-Long He
P2860
P304
P356
10.1002/JSO.23008
P577
2012-01-09T00:00:00Z